SCA Pharmaceuticals recalls Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only,
Recalled July 19, 2017 · FDA recall D-0978-2017 · SCA Pharmaceuticals
Hazard
Lack of sterility assurance · FDA Class II
Units
20 bags
Sold at
LA, PA, NY, WI
Description
Lack of sterility assurance
Product
Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-32
Manufacturer(s)
SCA Pharmaceuticals
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →